EQS-News: Formycon AG / Key word: Quarterly / Interim Statement/Conference
Formycon hosts conference call on the results of the first quarter 2024
02.05.2024 / 07:30.
Formycon reports audited annual results for the financial year 2023 – Looking back on a successful operative year and exceeded guidance marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Formycon, a Germany-based biosimilar manufacturer, shared that its revenues for 2023 were 83% higher than in 2022, reaching a total of €77.7 million, according to its annual earnings report.
EQS-News: Formycon AG / Key word(s): Conference/Annual ResultsFormycon invites to the conference call on the results of the financial year 2023 and announces participation in international investor conferences in the 2nd quarter of 2024 22.04.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of t.
EQS-News: Formycon AG / Key word: Conference/Annual Results
Formycon invites to the conference call on the results of the financial year 2023 and announces participation in.